News
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...
An experimental muscle-preserving drug called bimagrumab helped people taking semaglutide (Ozempic/Wegovy) keep their muscle ...
22h
MedPage Today on MSNADA Roundup: Weight-Loss Studies Take Center StageResearch presented at the American Diabetes Association (ADA) annual meeting included a small phase I/II study on stem cell ...
Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...
Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent ...
Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...
Full Phase 2 study results showed side effects that led people to stop treatment with MariTide, as well as weight loss ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
A single infusion of a new stem cell-based treatment may have helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report. The treatment, called zimislecel, was made ...
While Amgen’s monthly obesity candidate MariTide helped patients lose significant amounts of weight in a phase 2 study, ...
A strategy of time-restricted eating with energy restriction and intermittent energy restriction alone both conferred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results